🔔 Get instant alerts when NATCOPHARM files quarterly results on BSE Start free trial →

Natco Pharma Limited — Financials & Forensics

Sector: Healthcare · NSE: NATCOPHARM · BSE: 524816 · ISIN: INE987B01026

₹897.80
Closing price
18 Aug 2026
+2.7%
1-year price change
₹16,564 Cr
Market cap
11.7×
P/E ratio (trailing)
16.9%
Return on Equity (FY)
0.54%
Dividend yield
⚡ What you get within minutes of every filing
ISA
Indian Stock Alerts BOT
🚨 NATCOPHARM — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add NATCOPHARM to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime
NATCOPHARM price
→
Loading…
Compare with:
Loading chart…

Annual P&L snapshot

Line item FY22FY23FY24FY25FY26
Revenue from operations ₹1,945 Cr ₹2,707 Cr ₹3,999 Cr ₹4,430 Cr ₹4,078 Cr
EBITDA ₹264 Cr ₹936 Cr ₹1,751 Cr ₹2,196 Cr ₹1,436 Cr
EBITDA margin 13.6% 34.6% 43.8% 49.6% 35.2%
Profit after tax ₹170 Cr ₹715 Cr ₹1,388 Cr ₹1,883 Cr ₹1,418 Cr

Source: Natco Pharma Limited's regulatory filings under SEBI LODR Regulation 33. View full financials →

Deeper analysis

🔍 Forensic red-flag screen
Automated screen across audit / governance / accruals / RPT / pledge dimensions. Score, verdict and top flagged items.
🤝 Related-party transactions
RPT volume, transaction count, materiality flag from the latest SEBI integrated filing under Regulation 23(9).

Recent filings by Natco Pharma Limited

Never miss a filing again

1
Sign in with Google
2
Add stocks to watchlist
3
Get instant Telegram alerts
Get started — it's free →
14-day Pro trial included · No credit card required

About Natco Pharma Limited on Indian Stock Alerts

Indian Stock Alerts tracks Natco Pharma Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.

Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.

Important. All data on this page is sourced from Natco Pharma Limited's own public regulatory filings under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Investors should consult registered advisers before making investment decisions.
Notice a data issue? Filings are extracted automatically and may occasionally contain parse errors. Email support@indianstockalerts.com with the URL and we'll correct within 24 hours.